Reports
Reports
The global glycated haemoglobin testing market witnessed a healthy growth in the historical period of 2018-2022 aided by rising prevalence of diabetes. The market is expected to grow at a CAGR of 9% during the forecast period of 2023-2028.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America seems to have a major share in the glycated haemoglobin testing market owing to increasing incidence of diabetes in regions like the United States and Canada. Hectic lifestyles and mindless eating habits in the region have led to a surge in the demand for glucose testing, thereby driving the global glycated haemoglobin testing market. Rising awareness among people about diseases like diabetes is driving them to opt for treatments. Moreover, the increasing adoption of point-of-care testing facilities, especially in developed economies has contributed significantly to the global glycated haemoglobin testing market growth.
Glycated haemoglobin is measured to identify the three-month average plasma glucose concentration. Being a reliable index for long-term measure of glycemic level, the test is now considered as a cornerstone for diabetes management. The test is limited to a three-month average, owing to the four-month lifespan if red blood cells.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product type, the market can be segmented into:
Based on technology, the market can be bifurcated into:
Based on end use, the market can be divided into:
The regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Rising prevalence of diabetes across the globe is driving the global glycated haemoglobin testing market growth. The market is expected to register significant growth in the market since there’s only one therapy given to the patients. Moreover, increasing awareness in people regarding diabetes and the rising demand for new treatments is driving the market forward. In addition to this, glycated haemoglobin testing has observed growth owing to the availability of point-of-care HbA1c testing devices. The test provides significant advantages over traditional blood glucose monitoring assays, including high sample stability, low day-to-day variation and no prior fasting requirement. This, in turn, is expected to propel the market growth.
The report gives a detailed analysis of the following key players in the global glycated haemoglobin testing market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
The comprehensive EMR report provides an in-depth assessment of the industry based on Porter's five forces model along with giving a SWOT analysis.
REPORT FEATURES | DETAILS |
---|---|
Base Year | 2022 |
Historical Period | 2018-2022 |
Forecast Period | 2023-2028 |
Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product Type, Technology, End Use, Region |
Breakup by Product Type | Laboratory HbA1c Testing Products, Point of Care (POC) HbA1c Testing Products |
Breakup by Technology | Chromatography, Immunoassay, Others |
Breakup by End Use | Hospitals, Diagnostic Centers, Physical Examination Institution, Research Institutions, Others |
Breakup by Region | North America, Latin America, Europe, Middle East and Africa, Asia Pacific |
Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
Companies Covered | Abbott Laboratories, Siemens AG, Danaher Corp., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., Arkray, Inc., Others |
Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Glycated Haemoglobin Testing Market Analysis
8.1 Key Industry Highlights
8.2 Global Glycated Haemoglobin Testing Historical Market (2018-2022)
8.3 Global Glycated Haemoglobin Testing Market Forecast (2023-2028)
8.4 Global Glycated Haemoglobin Testing Market by Product Type
8.4.1 Laboratory HbA1c Testing Products
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2018-2022)
8.4.1.3 Forecast Trend (2023-2028)
8.4.2 Point of Care (POC) HbA1c Testing Products
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2018-2022)
8.4.2.3 Forecast Trend (2023-2028)
8.5 Global Glycated Haemoglobin Testing Market by Technology
8.5.1 Chromatography
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2018-2022)
8.5.1.3 Forecast Trend (2023-2028)
8.5.2 Immunoassay
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2018-2022)
8.5.2.3 Forecast Trend (2023-2028)
8.5.3 Others
8.6 Global Glycated Haemoglobin Testing Market by End Use
8.6.1 Hospitals
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2018-2022)
8.6.1.3 Forecast Trend (2023-2028)
8.6.2 Diagnostic Centers
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2018-2022)
8.6.2.3 Forecast Trend (2023-2028)
8.6.3 Physical Examination Institution
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2018-2022)
8.6.3.3 Forecast Trend (2023-2028)
8.6.4 Research Institutions
8.6.4.1 Market Share
8.6.4.2 Historical Trend (2018-2022)
8.6.4.3 Forecast Trend (2023-2028)
8.6.5 Others
8.7 Global Glycated Haemoglobin Testing Market by Region
8.7.1 North America
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2018-2022)
8.7.1.3 Forecast Trend (2023-2028)
8.7.2 Europe
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2018-2022)
8.7.2.3 Forecast Trend (2023-2028)
8.7.3 Asia Pacific
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2018-2022)
8.7.3.3 Forecast Trend (2023-2028)
8.7.4 Latin America
8.7.4.1 Market Share
8.7.4.2 Historical Trend (2018-2022)
8.7.4.3 Forecast Trend (2023-2028)
8.7.5 Middle East and Africa
8.7.5.1 Market Share
8.7.5.2 Historical Trend (2018-2022)
8.7.5.3 Forecast Trend (2023-2028)
9 North America Glycated Haemoglobin Testing Market Analysis
9.1 United States of America
9.1.1 Market Share
9.1.2 Historical Trend (2018-2022)
9.1.3 Forecast Trend (2023-2028)
9.2 Canada
9.2.1 Market Share
9.2.2 Historical Trend (2018-2022)
9.2.3 Forecast Trend (2023-2028)
10 Europe Glycated Haemoglobin Testing Market Analysis
10.1 United Kingdom
10.1.1 Market Share
10.1.2 Historical Trend (2018-2022)
10.1.3 Forecast Trend (2023-2028)
10.2 Germany
10.2.1 Market Share
10.2.2 Historical Trend (2018-2022)
10.2.3 Forecast Trend (2023-2028)
10.3 France
10.3.1 Market Share
10.3.2 Historical Trend (2018-2022)
10.3.3 Forecast Trend (2023-2028)
10.4 Italy
10.4.1 Market Share
10.4.2 Historical Trend (2018-2022)
10.4.3 Forecast Trend (2023-2028)
10.5 Others
11 Asia Pacific Glycated Haemoglobin Testing Market Analysis
11.1 China
11.1.1 Market Share
11.1.2 Historical Trend (2018-2022)
11.1.3 Forecast Trend (2023-2028)
11.2 Japan
11.2.1 Market Share
11.2.2 Historical Trend (2018-2022)
11.2.3 Forecast Trend (2023-2028)
11.3 India
11.3.1 Market Share
11.3.2 Historical Trend (2018-2022)
11.3.3 Forecast Trend (2023-2028)
11.4 ASEAN
11.4.1 Market Share
11.4.2 Historical Trend (2018-2022)
11.4.3 Forecast Trend (2023-2028)
11.5 Australia
11.5.1 Market Share
11.5.2 Historical Trend (2018-2022)
11.5.3 Forecast Trend (2023-2028)
11.6 Others
12 Latin America Glycated Haemoglobin Testing Market Analysis
12.1 Brazil
12.1.1 Market Share
12.1.2 Historical Trend (2018-2022)
12.1.3 Forecast Trend (2023-2028)
12.2 Argentina
12.2.1 Market Share
12.2.2 Historical Trend (2018-2022)
12.2.3 Forecast Trend (2023-2028)
12.3 Mexico
12.3.1 Market Share
12.3.2 Historical Trend (2018-2022)
12.3.3 Forecast Trend (2023-2028)
12.4 Others
13 Middle East and Africa Glycated Haemoglobin Testing Market Analysis
13.1 Saudi Arabia
13.1.1 Market Share
13.1.2 Historical Trend (2018-2022)
13.1.3 Forecast Trend (2023-2028)
13.2 United Arab Emirates
13.2.1 Market Share
13.2.2 Historical Trend (2018-2022)
13.2.3 Forecast Trend (2023-2028)
13.3 Nigeria
13.3.1 Market Share
13.3.2 Historical Trend (2018-2022)
13.3.3 Forecast Trend (2023-2028)
13.4 South Africa
13.4.1 Market Share
13.4.2 Historical Trend (2018-2022)
13.4.3 Forecast Trend (2023-2028)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Value Chain Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Company Profiles
16.2.1 Abbott Laboratories
16.2.1.1 Company Overview
16.2.1.2 Product Portfolio
16.2.1.3 Demographic Reach and Achievements
16.2.1.4 Certifications
16.2.2 Siemens AG
16.2.2.1 Company Overview
16.2.2.2 Product Portfolio
16.2.2.3 Demographic Reach and Achievements
16.2.2.4 Certifications
16.2.3 Danaher Corp.
16.2.3.1 Company Overview
16.2.3.2 Product Portfolio
16.2.3.3 Demographic Reach and Achievements
16.2.3.4 Certifications
16.2.4 Bio-Rad Laboratories, Inc.
16.2.4.1 Company Overview
16.2.4.2 Product Portfolio
16.2.4.3 Demographic Reach and Achievements
16.2.4.4 Certifications
16.2.5 Beckman Coulter, Inc.
16.2.5.1 Company Overview
16.2.5.2 Product Portfolio
16.2.5.3 Demographic Reach and Achievements
16.2.5.4 Certifications
16.2.6 Randox Laboratories Ltd.
16.2.6.1 Company Overview
16.2.6.2 Product Portfolio
16.2.6.3 Demographic Reach and Achievements
16.2.6.4 Certifications
16.2.7 Arkray, Inc.
16.2.7.1 Company Overview
16.2.7.2 Product Portfolio
16.2.7.3 Demographic Reach and Achievements
16.2.7.4 Certifications
16.2.8 Others
17 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Glycated Haemoglobin Testing Market: Key Industry Highlights, 2018 and 2028
2. Global Glycated Haemoglobin Testing Historical Market: Breakup by Product Type (USD Billion), 2018-2022
3. Global Glycated Haemoglobin Testing Market Forecast: Breakup by Product Type (USD Billion), 2023-2028
4. Global Glycated Haemoglobin Testing Historical Market: Breakup by Technology (USD Billion), 2018-2022
5. Global Glycated Haemoglobin Testing Market Forecast: Breakup by Technology (USD Billion), 2023-2028
6. Global Glycated Haemoglobin Testing Historical Market: Breakup by End Use (USD Billion), 2018-2022
7. Global Glycated Haemoglobin Testing Market Forecast: Breakup by End Use (USD Billion), 2023-2028
8. Global Glycated Haemoglobin Testing Historical Market: Breakup by Region (USD Billion), 2018-2022
9. Global Glycated Haemoglobin Testing Market Forecast: Breakup by Region (USD Billion), 2023-2028
10. North America Glycated Haemoglobin Testing Historical Market: Breakup by Country (USD Billion), 2018-2022
11. North America Glycated Haemoglobin Testing Market Forecast: Breakup by Country (USD Billion), 2023-2028
12. Europe Glycated Haemoglobin Testing Historical Market: Breakup by Country (USD Billion), 2018-2022
13. Europe Glycated Haemoglobin Testing Market Forecast: Breakup by Country (USD Billion), 2023-2028
14. Asia Pacific Glycated Haemoglobin Testing Historical Market: Breakup by Country (USD Billion), 2018-2022
15. Asia Pacific Glycated Haemoglobin Testing Market Forecast: Breakup by Country (USD Billion), 2023-2028
16. Latin America Glycated Haemoglobin Testing Historical Market: Breakup by Country (USD Billion), 2018-2022
17. Latin America Glycated Haemoglobin Testing Market Forecast: Breakup by Country (USD Billion), 2023-2028
18. Middle East and Africa Glycated Haemoglobin Testing Historical Market: Breakup by Country (USD Billion), 2018-2022
19. Middle East and Africa Glycated Haemoglobin Testing Market Forecast: Breakup by Country (USD Billion), 2023-2028
20. Global Glycated Haemoglobin Testing Market Structure
The market is projected to grow at a CAGR of 9% between 2021 and 2026.
The major drivers of the industry such as increasing prevalence of diabetes, availability of POC testing devices, and demand for new treatment methods are expected to aid the market growth.
The key market trend guiding the growth of the glycated haemoglobin testing market is a rise in R&D activities and demand for new treatments.
The major regions in the industry are North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
The types include laboratory HbA1c testing products and point of care (POC) HbA1c testing products.
The types of technology include chromatography and immunoassay, among others.
The major end-users in the industry are hospitals, diagnostic centers, physical examination institution, and research institution, among others.
The major players in the industry are Abbott Laboratories, Siemens AG, Danaher Corp., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., and Arkray, Inc., among others.
The global glycated haemoglobin testing market is being driven by rising prevalence of diabetes across the globe. Aided by the availability of point-of-care testing devices, the market is expected to witness further growth in the forecast period of 2023-2028, growing at a CAGR of 9%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By the type of products, the market can be bifurcated into laboratory HbA1c testing products and point of care (POC) HbA1c testing products. On the basis of technology, the major segments are chromatography, immunoassay, among others. Based on end users, the industry is majorly divided into hospitals, diagnostic centers, physical examination institution, and research institution, among others. The major regional markets for the product include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott Laboratories, Siemens AG, Danaher Corp., Bio-Rad Laboratories, Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., and Arkray, Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Mini Report
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.